155 related articles for article (PubMed ID: 23813743)
1. A randomised double-blind, cross-over trial of 4-aminopyridine for downbeat nystagmus--effects on slowphase eye velocity, postural stability, locomotion and symptoms.
Claassen J; Spiegel R; Kalla R; Faldon M; Kennard C; Danchaivijitr C; Bardins S; Rettinger N; Schneider E; Brandt T; Jahn K; Teufel J; Strupp M; Bronstein A
J Neurol Neurosurg Psychiatry; 2013 Dec; 84(12):1392-9. PubMed ID: 23813743
[TBL] [Abstract][Full Text] [Related]
2. 4-aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus.
Kalla R; Glasauer S; Büttner U; Brandt T; Strupp M
Brain; 2007 Sep; 130(Pt 9):2441-51. PubMed ID: 17664175
[TBL] [Abstract][Full Text] [Related]
3. Does 4-aminopyridine "beat" downbeat nystagmus?
Shaikh AG
J Neurol Neurosurg Psychiatry; 2013 Dec; 84(12):1298-9. PubMed ID: 23833267
[No Abstract] [Full Text] [Related]
4. Effect of chlorzoxazone in patients with downbeat nystagmus: a pilot trial.
Feil K; Claaßen J; Bardins S; Teufel J; Krafczyk S; Schneider E; Schniepp R; Jahn K; Kalla R; Strupp M
Neurology; 2013 Sep; 81(13):1152-8. PubMed ID: 23975871
[TBL] [Abstract][Full Text] [Related]
5. Dalfampridine in patients with downbeat nystagmus--an observational study.
Claassen J; Feil K; Bardins S; Teufel J; Spiegel R; Kalla R; Schneider E; Jahn K; Schniepp R; Strupp M
J Neurol; 2013 Aug; 260(8):1992-6. PubMed ID: 23589193
[TBL] [Abstract][Full Text] [Related]
6. Comparison of 10-mg doses of 4-aminopyridine and 3,4-diaminopyridine for the treatment of downbeat nystagmus.
Kalla R; Spiegel R; Claassen J; Bardins S; Hahn A; Schneider E; Rettinger N; Glasauer S; Brandt T; Strupp M
J Neuroophthalmol; 2011 Dec; 31(4):320-5. PubMed ID: 21734596
[TBL] [Abstract][Full Text] [Related]
7. Effect of 3,4-diaminopyridine on the postural control in patients with downbeat nystagmus.
Sprenger A; Zils E; Rambold H; Sander T; Helmchen C
Ann N Y Acad Sci; 2005 Apr; 1039():395-403. PubMed ID: 15826992
[TBL] [Abstract][Full Text] [Related]
8. Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.
Strupp M; Schüler O; Krafczyk S; Jahn K; Schautzer F; Büttner U; Brandt T
Neurology; 2003 Jul; 61(2):165-70. PubMed ID: 12874393
[TBL] [Abstract][Full Text] [Related]
9. Effect of 4-aminopyridine on gravity dependence and neural integrator function in patients with idiopathic downbeat nystagmus.
Sander T; Sprenger A; Marti S; Naumann T; Straumann D; Helmchen C
J Neurol; 2011 Apr; 258(4):618-22. PubMed ID: 21057959
[TBL] [Abstract][Full Text] [Related]
10. Modelling drug modulation of nystagmus.
Glasauer S; Rössert C
Prog Brain Res; 2008; 171():527-34. PubMed ID: 18718349
[TBL] [Abstract][Full Text] [Related]
11. GAA-FGF14 disease: defining its frequency, molecular basis, and 4-aminopyridine response in a large downbeat nystagmus cohort.
Pellerin D; Heindl F; Wilke C; Danzi MC; Traschütz A; Ashton C; Dicaire MJ; Cuillerier A; Del Gobbo G; Boycott KM; Claassen J; Rujescu D; Hartmann AM; Zuchner S; Brais B; Strupp M; Synofzik M
EBioMedicine; 2024 Apr; 102():105076. PubMed ID: 38507876
[TBL] [Abstract][Full Text] [Related]
12. Effect of 4-aminopyridine on upbeat and downbeat nystagmus elucidates the mechanism of downbeat nystagmus.
Glasauer S; Strupp M; Kalla R; Büttner U; Brandt T
Ann N Y Acad Sci; 2005 Apr; 1039():528-31. PubMed ID: 15827015
[TBL] [Abstract][Full Text] [Related]
13. Clinical use of 4-aminopyridine in patients with downbeat nystagmus.
Domínguez-Durán E; Mármol-Szombathy I; Baños-Roldán Ú; Sánchez-Gómez S
Acta Otorrinolaringol Esp (Engl Ed); 2020; 71(1):40-44. PubMed ID: 31078225
[TBL] [Abstract][Full Text] [Related]
14. Transition from downbeat to upbeat nystagmus caused by 4-aminopyridine.
Feil K; Claaßen J; Bardins S; Teufel J; Habs M; Kalla R; Strupp M
J Neurol; 2013 May; 260(5):1426-8. PubMed ID: 23595790
[No Abstract] [Full Text] [Related]
15. 4-aminopyridine restores visual ocular motor function in upbeat nystagmus.
Glasauer S; Kalla R; Büttner U; Strupp M; Brandt T
J Neurol Neurosurg Psychiatry; 2005 Mar; 76(3):451-3. PubMed ID: 15716550
[TBL] [Abstract][Full Text] [Related]
16. 4-aminopyridine improves downbeat nystagmus, smooth pursuit, and VOR gain.
Kalla R; Glasauer S; Schautzer F; Lehnen N; Büttner U; Strupp M; Brandt T
Neurology; 2004 Apr; 62(7):1228-9. PubMed ID: 15079036
[No Abstract] [Full Text] [Related]
17. Real-time computer-based visual feedback improves visual acuity in downbeat nystagmus - a pilot study.
Teufel J; Bardins S; Spiegel R; Kremmyda O; Schneider E; Strupp M; Kalla R
J Neuroeng Rehabil; 2016 Jan; 13():1. PubMed ID: 26728632
[TBL] [Abstract][Full Text] [Related]
18. Update on the Pharmacotherapy of Cerebellar Ataxia and Nystagmus.
Feil K; Bremova T; Muth C; Schniepp R; Teufel J; Strupp M
Cerebellum; 2016 Feb; 15(1):38-42. PubMed ID: 26519380
[TBL] [Abstract][Full Text] [Related]
19. Effects of 4-aminopyridine on nystagmus and vestibulo-ocular reflex in ataxia-telangiectasia.
Shaikh AG; Marti S; Tarnutzer AA; Palla A; Crawford TO; Zee DS; Straumann D
J Neurol; 2013 Nov; 260(11):2728-35. PubMed ID: 23884713
[TBL] [Abstract][Full Text] [Related]
20. Intronic
Pellerin D; Heindl F; Wilke C; Danzi MC; Traschütz A; Ashton C; Dicaire MJ; Cuillerier A; Del Gobbo G; Boycott KM; Claassen J; Rujescu D; Hartmann AM; Zuchner S; Brais B; Strupp M; Synofzik M
medRxiv; 2023 Aug; ():. PubMed ID: 37577458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
